Media

Filter:

Blog

Taking compounds from clinical to commercial: An investment-led strategy

Our Business Development Lead Kamilla Rolsted discusses her career and the trials and tribulations of securing investment in the competitive and highly niche field of rare disease.

Blog

From cancer research pioneer to rare disease breakthroughs – Michael’s 30-year journey

Our very own Michael Braunagel takes us through his three-decade-long career spanning three countries, ranging from cutting edge cancer research to developing a potentially groundbreaking clinical treatment in the field of rare diseases.